ANEBULO PHARMACEUTICALS INC (ANEB) Stock Cash Flow
USA - NASDAQ:ANEB - US0345691036 - Common Stock
2.28 USD
-0.09 (-3.8%)
| 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.48M | -8.20M | -11.73M | -6.83M | -30.25M | |||
| Depreciation Amortization | null | null | null | null | null | |||
| Income Taxes - Deferred | null | null | null | null | null | |||
| Accounts Payable And Accrued Liabilities | undefined | undefined | undefined | undefined | undefined | |||
| Change In Working Capital | 306.20K | -799.30K | 1.16M | 910.00K | -1.45M | |||
| Interest Paid | null | null | null | 0 | 10.00K | |||
| Taxes Paid | null | null | null | null | null | |||
| Other non cash items | 1.83M | 910.10K | 880.00K | 480.00K | 26.83M | |||
| OPERATING CASH FLOW | -6.35M | -8.09M | -9.68M | -5.44M | -4.87M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | null | null | null | null | null | |||
| Other Investing Activity | null | null | null | null | null | |||
| INVESTING CASH FLOW | null | null | null | null | null | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | null | null | null | 0 | -200.00K | |||
| Stock Issued/Repurchased | 15.00M | null | 6.70M | 0 | 22.85M | |||
| Dividend Paid | null | null | null | null | null | |||
| Other Financing Activity | -116.70K | -62.40K | -320.00K | 0 | -820.00K | |||
| FINANCING CASH FLOW | 14.88M | -62.40K | 6.38M | 0 | 21.83M | |||
| Exchange Rate Effect | null | null | null | null | null | |||
| CHANGE IN CASH | 8.53M | -8.15M | -3.30M | -5.44M | 16.96M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.35M | -8.09M | -9.68M | -5.44M | -4.87M | |||
| Capital Expenditure | null | null | null | null | null | |||
| FREE CASH FLOW | -6.35M | -8.09M | -9.68M | -5.44M | -4.87M | |||
All data in USD